Cubist Systematic Strategies, LLC Moderna, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 316,500 shares of MRNA stock, worth $8.42 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
316,500
Previous 55,802
467.18%
Holding current value
$8.42 Million
Previous $2.32 Million
286.72%
% of portfolio
0.06%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
251MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$680 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$588 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$473 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$198 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...